UNCY (Unicycive Therapeutics) Short Interest


UNCY Unicycive Therapeutics Inc UNCY
30 GF Score
Price $5.73
! 2 Warning Signs
View Full Analysis

What is Unicycive Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

UNCY vs MDWD, ARCT, NGEN: Short Interest Comparison

For the Biotechnology subindustry, Unicycive Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unicycive Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Unicycive Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Unicycive Therapeutics's Short Interest falls into.


UNCY
30GF Score
Unicycive Therapeutics Inc UNCY
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unicycive Therapeutics Business Description

Address 1975 W. El Camino Real, Suite 204, Mountain View, CA, USA, 94040
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
30GF Score

Get the complete analysis for UNCY

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.73
Price